王老吉品牌怎么样 申请店铺

我要投票 王老吉在凉茶行业中的票数:181 更新时间:2025-03-14
王老吉是哪个国家的品牌?「王老吉」是 广州白云山医药集团股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人李楚源在1997-09-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力王老吉品牌出海!通过在本页面挂载王老吉品牌的产品链接和联系邮箱,可以提高王老吉产品曝光!跨境电商爆单神器,目前只要100元/年哦~

王老吉怎么样

广州王老吉药业股份有限公司始创于1828年,历经百多年的发展,现已成为我国中成药生产企业50强之一,曾荣获“中华老字号”、“全国先进集体”、“广东省医药行业质量效益型先进企业”和中国五星级企业等荣誉称号以及获得广州市银信评估咨询有限公司颁发AAA级信用等级证书(见下图)等。

王老吉药业拥有先进的厂房设备,管理规范、获得国家药检局颁发的GMP证书。主要产品有王老吉系列、保济丸、保济口服液、小儿七星茶、清热暗疮片、克感利咽口服液、痰咳净、藿胆丸等,其中王老吉清凉茶、王老吉广东凉茶颗粒、保济丸、痰咳净等都被评为“广东省、广州市名牌产品”和“中国中药名牌产品”……

王老吉药业一贯重视技术创新与技术进步,公司内各类专业技术人员约占员工总数的50%。公司承担的“二氧化碳超临界萃取仪技术在中草药中的应用研究与开发”项目获广东省科技进步二等奖、广州市科技进步一等奖;首家建成全自动立体仓库;自行研制成功具国内外先进水平的全自动保济丸包装机,生产效率为引进的日本包装机的4倍……

公司积极与科研单位及大专院校合作,运用中药现代化最新的“三超”技术研制保济片、克感利咽口服液等新产品。克感利咽口服液因在非典期间表现出对流感病毒和呼吸道常见致病菌有明显抑止作用,被列为“广东省抗SARA和流感的重点科研攻关项目”;公司还与南丹麦大学签署了《克感利咽口服液抗病毒机理的研究》专项科技合作项目,以“科技输出”的形式成为欧盟传统药品法生效后,国内首家进入欧盟的企业……

王老吉药业一直热心资助社会弱势群体,积极参与社会公益事业……

2005年,香港同兴药业强势加盟王老吉。香港同兴药业拥有雄厚的资本,具有超前的经营理念,管理科学、先进,特别是在中药海外销售方面积累了丰富的经验,在香港和东南亚地区拥有庞大的中药销售网络,将为王老吉产品进入国际市场打通渠道。

展望未来,王老吉药业将继续按照十六大提出的“走新型工业化路子”的目标,以信息化推动工业化,把公司建设成为科技含量高、经济效益好、资源消耗低、环境污染少、人力资源优势得到充分发挥的具有中国特色的社会主义新型工业企业。

Founded in 1828, Guangzhou Wanglaoji Pharmaceutical Co., Ltd. has become one of the top 50 Chinese patent medicine manufacturing enterprises after more than 100 years of development. It has won the honorary titles of "China Time-honored Brand", "national advanced collective", "Guangdong Province pharmaceutical industry quality and efficiency advanced enterprise" and China's five-star enterprise, and has been awarded a by Guangzhou Yinxin evaluation and Consulting Co., Ltd AA credit rating certificate (see figure below), etc. Wang Laoji pharmaceutical has advanced plant equipment, standardized management and GMP certificate issued by the State Drug Inspection Bureau. The main products are Wanglaoji series, Baoji pill, Baoji oral liquid, xiaoerqixing tea, Qingre Mengchuang tablet, keyanliyan oral liquid, tankejing, Huodan pill, etc., among which Wanglaoji Qingliang tea, Wanglaoji Guangdong Liangcha granule, Baoji pill and tankejing are all rated as "famous brand products of Guangdong Province and Guangzhou City" and "famous brand products of Chinese traditional medicine" Wang Laoji has always attached great importance to technological innovation and technological progress. All kinds of professional and technical personnel in the company account for about 50% of the total number of employees. The project of "application research and development of carbon dioxide supercritical extractor technology in Chinese herbal medicine" undertaken by the company won the second prize of Guangdong Province Science and technology progress and the first prize of Guangzhou City Science and technology progress; the first to build a full-automatic three-dimensional warehouse; the self-developed full-automatic Baoji pill packaging machine with advanced level at home and abroad, with the production efficiency four times that of the imported Japanese packaging machine The company actively cooperates with scientific research institutions and colleges and universities to develop new products such as Baoji tablet and keyanliyan oral liquid by using the latest "three super" technology of traditional Chinese medicine. Keganliyan oral liquid was listed as "the key scientific research project of anti Sara and influenza in Guangdong Province" because of its obvious inhibitory effect on influenza virus and common respiratory pathogens during SARS; The company also signed a special scientific and technological cooperation project with the University of Southern Denmark on the antiviral mechanism of keyanliyan oral liquid, which became the first domestic enterprise to enter the European Union in the form of "scientific and technological output" after the EU traditional drug law came into effect Wang Laoji pharmaceutical has always been keen to support the social vulnerable groups and actively participate in social public welfare undertakings In 2005, Hong Kong Tongxing pharmaceutical industry joined Wang Laoji. Hong Kong Tongxing Pharmaceutical Co., Ltd. has abundant capital, advanced business philosophy, scientific management and rich experience in overseas sales of traditional Chinese medicine. It has a huge sales network of traditional Chinese medicine in Hong Kong and Southeast Asia, which will open up channels for Wang Laoji's products to enter the international market. Looking forward to the future, Wang Laoji pharmaceutical will continue to follow the goal of "taking a new road of industrialization" put forward by the 16th National Congress of the Communist Party of China, promote industrialization with information technology, and build the company into a new socialist industrial enterprise with Chinese characteristics with high technology content, good economic benefits, low resource consumption, less environmental pollution and full play of human resource advantages.

本文链接: https://brand.waitui.com/ee893c0e9.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

阿联酋航空服务公司DAE斥资近10亿美元购买17架飞机

阿联酋航空服务公司Dubai Aerospace Enterprise(DAE)3月14日宣布,日前签署多项协议,以近10亿美元总对价购买17架飞机。声明称,该投资组合中均为新一代飞机,其中89%为窄体,空客与波音飞机占比分别为80%和20%。DAE表示,这17架飞机将租给10个国家的11家航空公司。(界面)

2小时前

茶百道:补贴加盟商力度加大,预计2024年经调净利润5.8亿至7.09亿元

3月14日晚间,茶百道发布业绩预告,预计2024年录得经调整净利润约5.8亿元至7.09亿元。公告显示,受2024年公司整体市场投入费用增加、对加盟商的政策及费用支持加大等影响,报告期内利润出现暂时性波动。分析人士表示,前述加大对加盟商的扶持力度,有望帮助茶百道借规模效益实现向下整合。

2小时前

中航高科:2024年净利润11.53亿元,同比增长11.75%

36氪获悉,中航高科发布2024年度报告。报告显示,2024年公司实现营业收入50.72亿元,同比增长6.12%;净利润11.53亿元,同比增长11.75%。公司拟以总股本13.93亿股为基数,每10股派送现金股利2.49元(含税),共计分配股利3.47亿元。

2小时前

李强:针对今年形势和任务的特点,要更加注重加大政策力度和激发市场力量良性互动、协同发力

国务院总理李强3月14日主持召开国务院第八次全体会议。李强指出,针对今年形势和任务的特点,要更加注重加大政策力度和激发市场力量良性互动、协同发力。实施好更加积极有为的宏观政策,最大限度发挥政策效应。着力深化改革,完善法治环境和信用环境,调动各类经营主体的积极性主动性。要切实守住底线,努力追求高线。在牢牢守住安全稳定等底线的同时,以更高的目标追求和工作标准,在发展新质生产力、做强国内大循环、加快绿色转型、增进民生福祉等方面取得更大成效,打造更多突破性、标志性成果。(第一财经)

2小时前

深交所:本周对存在退市风险的“*ST旭蓝”进行重点监控

36氪获悉,3月10日至3月14日,深交所共对127起证券异常交易行为采取了自律监管措施,涉及盘中拉抬打压、虚假申报等异常交易情形;对存在退市风险的“*ST旭蓝”进行重点监控;共对4起上市公司重大事项进行核查,并上报证监会2起涉嫌违法违规案件线索。

2小时前

本页详细列出关于润心堂的品牌信息,含品牌所属公司介绍,润心堂所处行业的品牌地位及优势。
咨询